Nucala 100 MG/ML auto-injectorml
Ended Awarded Last action
- Contract number
- SPE2DR26FCZH8
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,455
Award facts
- Contract value 100% obligated
- $15,454.64 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,454.64 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, on January 27, 2026. The delivery order is for NUCALA 100 mg/ml auto-injector, a biologic medication used in the treatment of asthma and other eosinophilic conditions. No set-aside designation was used in this competitive award. The contract was funded by the Defense Logistics Agency and is set to be completed by January 28, 2026, with performance taking place at the awardee's location in Park Ridge, Illinois.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), a $30.3 billion government-wide acquisition strategy designed to streamline pharmaceutical procurement for Department of Defense healthcare facilities worldwide. The PPV-G GEN V contract held by DMS Pharmaceutical Group, valued at $499,999,999 with a completion date of December 31, 2036, authorizes the issuance of delivery orders for a comprehensive range of prescription drugs, biologics, and medical consumables to support military medical supply needs globally. As a registered federal contractor since 2001, DMS Pharmaceutical Group has demonstrated consistent performance across numerous delivery orders and serves as a critical supplier within the federal pharmaceutical supply chain for military healthcare operations.
Quick answers
Who was awarded contract SPE2DR26FCZH8?
SPE2DR26FCZH8 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 27, 2026.
How much is contract SPE2DR26FCZH8 worth?
The government has obligated $15,455 on SPE2DR26FCZH8.
Is contract SPE2DR26FCZH8 an order under another contract?
Yes. SPE2DR26FCZH8 is a delivery order under SPE2DR25D9127, an indefinite delivery contract.
Was contract SPE2DR26FCZH8 competed?
The extent of competition for SPE2DR26FCZH8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award